Venous thromboembolism (VTE) including pulmonary embolism (PE) and deep vein
thrombosis (DVT) is one of the leading causes of preventable cardiovascular disease in the …

Despite considerable progress in the diagnosis and treatment of deep‐vein thrombosis
(DVT) of the lower extremities, one of every 2–3 patients will develop within 2 years post …

Methods Members of the writing panel were invited by the American Heart Association
Scientific Council leadership because of their multidisciplinary expertise in PTS. Writing …

Venous thromboembolism (VTE) is often asymptomatic, misdiagnosed, and unrecognized at
death, and there is a lack of routine postmortem examinations. These factors are thought to …

Background: The influence of the duration of anticoagulant therapy after venous
thromboembolism (VTE) on the long‐term morbidity and mortality is unclear. Aim: To …

Background: The post-thrombotic syndrome (PTS) is a frequent complication of deep vein
thrombosis (DVT). Patients with recurrent ipsilateral DVT have an increased risk of PTS; …

Up to half of patients with proximal deep vein thrombosis (DVT) will develop post-thrombotic
syndrome (PTS) despite optimal anticoagulant therapy. PTS significantly impacts upon …

The post thrombotic syndrome (PTS) refers to clinical manifestations of chronic venous
insufficiency (CVI) following a deep-vein thrombosis (DVT). PTS is the most frequent …

Venous thromboembolism (VTE) is a common disease (~ 700 per 100 000) that is
associated with significant risk of recurrence, chronic complications, and substantial …

Objective: To determine the long-term incidence, risk factors, and associated morbidity and
mortality of recurrent deep vein thrombosis (DVT). Summary Background Data: Few studies …